Tong Chen

12 Wulumuqi Middle Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88L265P-induced PIM1 stability.

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88L265P-induced PIM1 stability.

Journal: Journal of hematology & oncology

Published: January 31, 2026

In vitro experiment and computational fluid dynamics simulation study on blood pump for total cavopulmonary connection circulation.

In vitro experiment and computational fluid dynamics simulation study on blood pump for total cavopulmonary connection circulation.

Journal: Frontiers in bioengineering and biotechnology

Published: January 21, 2025

Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma.

Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma.

Journal: Neoplasia (New York, N.Y.)

Published: June 11, 2024

Study on the optimal elastic modulus of flexible blades for right heart assist device supporting patients with single-ventricle physiologies.

Study on the optimal elastic modulus of flexible blades for right heart assist device supporting patients with single-ventricle physiologies.

Journal: Frontiers in cardiovascular medicine

Published: January 28, 2024

Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia.

Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia.

Journal: Annals of hematology

Published: August 22, 2023

Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.

Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.

Journal: Journal of hematology & oncology

Published: August 04, 2022

Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study.

Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study.

Journal: Annals of hematology

Published: May 10, 2022

Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8+ T cells.

Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8+ T cells.

Journal: Cell death & disease

Published: April 01, 2022

CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway.

CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway.

Journal: Cell death & disease

Published: February 19, 2022

A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy.

A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy.

Journal: Therapeutic advances in hematology

Published: October 12, 2021

Current and emerging therapies for primary central nervous system lymphoma.

Current and emerging therapies for primary central nervous system lymphoma.

Journal: Biomarker research

Published: February 17, 2021

ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.

ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.

Journal: Oncogene

Published: December 27, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026